Manulife (Manufacturers Life Insurance)’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$51.8K Sell
20,979
-3,945
-16% -$9.74K ﹤0.01% 2884
2025
Q1
$49.6K Buy
24,924
+1,332
+6% +$2.65K ﹤0.01% 2834
2024
Q4
$68.9K Buy
23,592
+197
+0.8% +$575 ﹤0.01% 2888
2024
Q3
$90.5K Sell
23,395
-743
-3% -$2.88K ﹤0.01% 2887
2024
Q2
$124K Sell
24,138
-50,790
-68% -$261K ﹤0.01% 2769
2024
Q1
$524K Buy
74,928
+10,381
+16% +$72.7K ﹤0.01% 2193
2023
Q4
$572K Sell
64,547
-113
-0.2% -$1K ﹤0.01% 2120
2023
Q3
$617K Buy
64,660
+6,259
+11% +$59.7K ﹤0.01% 2028
2023
Q2
$856K Buy
58,401
+12,770
+28% +$187K ﹤0.01% 1742
2023
Q1
$561K Buy
45,631
+642
+1% +$7.9K ﹤0.01% 1939
2022
Q4
$887K Buy
+44,989
New +$887K ﹤0.01% 1670